ERBB2 and colorectal carcinoma: When examining HER2 amplification by race, we found that the incidence of HER2 amplification was highest in Asian patients with CRC (3.9%, 9/228), followed by Black patients with CRC (3.0%, 9/298), and then Caucasian patients with CRC (2.7%, 57/2118).